| 1. |
- Bergenfelz, A, et al.
(författare)
-
Biochemical variables associated with bone density in patients with primary hyperparathyroidism
- 1992
-
Ingår i: European Journal of Surgery, Acta Chirurgica. - 1102-4151. ; 158:9, s. 6-473
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: To clarify the association between primary hyperparathyroidism and cortical osteopenia.DESIGN: Open study.SETTING: Department of Surgery, University of Lund, Sweden.SUBJECTS: 38 patients with primary hyperparathyroidism.OUTCOME MEASURES: Correlation between bone density (measured by single photon absorption) and age; sex; serum concentrations of parathyroid hormone and ionised calcium; serum alkaline phosphatase activity; and serum concentration of calcium, phosphate, creatinine, urea, osteocalcin, 25 hydroxycholecalciferol, and 1,25 dihydroxycholecalciferol.RESULTS: There was no difference in bone density between men and women. There was no correlation between bone density and severity of hypercalcaemia or age. No biochemical abnormality was peculiar to the seven patients whose bone density was more than two SD below the population mean. Serum concentrations of 1,25 dihydroxycholecalciferol and osteocalcin both correlated significantly with bone density (p < 0.05) and there was a strong correlation between serum osteocalcin and serum intact parathyroid hormone (p < 0.001). Serum osteocalcin had the strongest correlation with bone density of any of the biochemical variables.CONCLUSION: There is little association between bone density and serum concentration of parathyroid hormone.
|
|
| 2. |
- Bergenfelz, A, et al.
(författare)
-
Prediction of changes in bone density after operation for primary hyperparathyroidism
- 1993
-
Ingår i: Annales Chirurgiae et Gynaecologiae. - 0355-9521. ; 82:4, s. 9-245
-
Tidskriftsartikel (refereegranskat)abstract
- Primary hyperparathyroidism (pHPT) is associated with osteopenia. However, the individual variation in recovery in bone mass after surgery is large. Therefore, modes of prediction of the increase in bone mass after parathyroid surgery were investigated. Preoperatively and at one year after surgery bone mineral content (BMC) in the distal radius was measured with single photon absorptiometry technique in 40 patients with pHPT. Serum levels of calcium, intact parathyroid hormone (PTH), alkaline phosphatase, osteocalcin and Vitamin D metabolites were also determined. Preoperatively, Z-score of BMC was -0.85 +/- 1.20 SD below the normal mean. There was a modest association between BMC and serum levels of osteocalcin (r = -0.34; P < 0.05), and dihydroxycholecalciferol (r = -0.35; P < 0.05). At one year after surgery, mean BMC increased by 2% (P < 0.05), but with a wide dispersion. Preoperative Z-score of BMC correlated with the relative change in BMC (r = -0.33; P < 0.05). An increase in BMC with 95% confidence was evident in 10 of the patients. None of these patients had a preoperative Z-score of BMC above the mean expected for age and sex. We conclude that the increase in bone mass after surgery for pHPT is small and evident only in a portion (approximately 25%) of patients. Hence, a decrease in bone mass should not be a major indication for surgery in pHPT.
|
|
| 3. |
- Grama, D, et al.
(författare)
-
Clinical characteristics, treatment and survival of pancreatic tumors causing hormonal syndromes
- 1992
-
Ingår i: World Journal of Surgery. - 0364-2313 .- 1432-2323. ; 16:4, s. 632-639
-
Tidskriftsartikel (refereegranskat)abstract
- Eighty-five patients with endocrine pancreatic tumors associated with clinical syndromes of hormone excess were retrospectively analyzed regarding symptomatology, means of diagnosis, and results of surgical and medical treatment during follow-up of 3-18 years (median 8 years). The combination of angiography and computed tomography was most successful in pre-operative localization of both primary tumors and metastases. Surgery provided long term cure in 39 of 44 patients with benign islet cell lesions, the majority having insulinomas. Forty-one patients had malignant tumors, which at the time of diagnosis or operation were associated with liver and/or regional lymph gland metastases in 56% and 24%, respectively. Sixteen patients with metastatic disease and/or very large tumors were considered inoperable, 5 patients underwent palliative resection of their malignant tumors, while grossly radical tumor removal was accomplished in 20 patients. Long-term cure was achieved in 5 patients by excision of primary tumors and localized liver or lymph gland metastases. Half of the patients, particularly those with insulinoma, gastrinoma, or vipoma, showed response to streptozotocin, in combination with other cytostatics, for a median of 24 months or a response to interferon for a median of 10 months. The overall 5-year and 10-year survival among the patients with malignant islet cells tumors was 54% and 28%, respectively. Absence of liver metastases at time of operation/diagnosis, smaller size of the primary tumor, grossly radical tumor resection as well as response to medical therapy predicted the more favorable survival.
|
|
| 4. |
- Grama, D, et al.
(författare)
-
Pancreatic tumors in multiple endocrine neoplasia type 1 : clinical presentation and surgical treatment
- 1992
-
Ingår i: World Journal of Surgery. - 0364-2313 .- 1432-2323. ; 16:4, s. 611-618
-
Tidskriftsartikel (refereegranskat)abstract
- Among 33 patients with endocrine pancreatic tumors due to multiple endocrine neoplasia type 1 (MEN-1), 19 (58%) patients had hypergastrinemia, 7 (21%) patients had hyperinsulinism, and 7 (21%) patients had clinically non-functioning lesions. At least one gross tumor was found in all patients undergoing pancreatic surgery, including those with negative localization studies prior to operation. The patients also had additional macroscopic tumors as well as numerous microadenomas, and the lesions frequently were positive for immunostaining with multiple hormones, mainly pancreatic polypeptide, insulin, glucagon, and somatostatin. Duodenal endocrine lesions were found in 4 of 5 investigated patients and stained with gastrin and somatostatin antibodies. Distal, mainly subtotal pancreatic resection, was performed in 18 patients, eventually combined with caput tumor enucleation or duodenotomy, while a few patients underwent only tumor enucleation or a Whipple procedure. The long-term outcome of operation was most favorable in patients with hyperinsulinism; only 1 patient had clinical recurrence. Patients with hypergastrinemia experienced only transitory lowering of serum gastrin values after pancreatic surgery and 47% of them had or developed metastases. Such tumor spread was seen in 57% of the patients with non-functioning lesions. Nine patients died from progressive tumor disease during follow-up. Consistent with previous studies, we found that surgery is indicated in MEN-1 patients with hyperinsulinism even if a lesion is not visualized by radiology. In addition, these indications should be extended to also include patients with only biochemical markers of disease, including elevations of gastrin, as these indicate the presence of gross tumors.
|
|
| 5. |
- Ahrén, B, et al.
(författare)
-
Potential clinical use of the EDTA-infusion test
- 1993
-
Ingår i: European Journal of Clinical Chemistry and Clinical Biochemistry. - 0939-4974. ; 31:6, s. 8-353
-
Tidskriftsartikel (refereegranskat)abstract
- The introduction of assays for the intact parathyrin (parathyroid hormone) has dramatically improved the diagnosis and follow-up of patients with primary hyperparathyroidism. However, in some patients with mild or intermittent hypercalcaemia, when plasma concentrations of intact parathyrin may be within the normal reference concentrations, the diagnosis of primary hyperparathyroidism may still be problematic. In these patients, the EDTA-infusion test is of potential value, as it also might be in patients with equivocal operative findings.
|
|
| 6. |
- Bergenfelz, A, et al.
(författare)
-
Calcium metabolism after hemithyroidectomy
- 1993
-
Ingår i: Hormone Research. - : S. Karger AG. - 0301-0163 .- 1423-0046. ; 39:1-2, s. 56-60
-
Tidskriftsartikel (refereegranskat)abstract
- It is not known whether thyroid surgery evokes changes in calcium metabolism. We therefore studied 6 patients operated upon with hemithyroidectomy for benign thyroid diseases, preoperatively and at 3 months and 1 year postoperatively. We measured changes in serum levels of intact parathyroid hormone (PTH), vitamin D metabolites, ionized calcium, phosphate, osteocalcin, thyroid hormones and bone density. Further, the dynamic function of the parathyroid glands was investigated by an oral calcium load test pre- and at 3 months postoperatively. At follow-up, all patients were euthyroid. During the oral calcium load, serum levels of intact PTH were reduced by the same degree before and after hemithyroidectomy, showing normal parathyroid function. Serum levels of 1,25-dihydroxyvitamin D declined from 86 +/- 16 to 57 +/- 4 pmol/l (p < 0.01) at 1 year after hemithyroidectomy, and serum levels of phosphate increased slightly from 0.96 +/- 0.08 to 1.06 +/- 0.08 mmol/l (p < 0.05), whereas serum levels of ionized calcium, intact PTH, osteocalcin and bone density did not change. Our results demonstrate that thyroid operation evokes changes in vitamin D metabolism in spite of normal parathyroid function.
|
|
| 7. |
- Bergenfelz, A, et al.
(författare)
-
Functional recovery of the parathyroid glands after surgery for primary hyperparathyroidism
- 1994
-
Ingår i: Surgery. - 0039-6060. ; 116:5, s. 36-827
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: The immediate postoperative function of the parathyroid glands after surgery for primary hyperparathyroidism (pHPT) has not been established. We therefore examined the influences of hypercalcemia and hypocalcemia on serum parathyroid hormone (PTH) levels in the immediate postoperative period in patients with pHPT.METHODS: Ethylenediaminetetraacetic acid was infused in patients on the first (n = 5) and fourth (n = 6) postoperative days, and in patients at 1 year after surgery (n = 6), and in healthy subjects (n = 7). Calcium was given orally before operation and on the second and fifth postoperative days in six patients and in seven healthy subjects.RESULTS: The increased set point seen in pHPT was normalized on the first postoperative day, and the decreased PTH suppressibility by calcium was normal on the second postoperative day. However, on the fifth postoperative day an increased suppressibility of PTH was evident. During the ethylenediaminetetraacetic acid infusion test the secretory reserve for PTH increased after operation with increasing hypocalcemia-induced levels of intact PTH between the first and fourth postoperative days (p < 0.001), and between the fourth postoperative day and the test at 1 year (p < 0.05).CONCLUSIONS: In the immediate postoperative period after surgery for pHPT, baseline serum levels of PTH are rapidly normalized; this is followed by an increase in the secretory reserve for PTH secretion and the development of an increased sensitivity to calcium.
|
|
| 8. |
- Bergenfelz, A, et al.
(författare)
-
Hyperthyroxinemia after surgery for primary hyperparathyroidism
- 1994
-
Ingår i: Langenbecks Archiv für Chirurgie. - 0023-8236. ; 379:3, s. 81-178
-
Tidskriftsartikel (refereegranskat)abstract
- Episodes of transient thyrotoxicosis after surgery for primary hyperparathyroidism have previously been described, and surgical trauma to the thyroid gland has been suggested as an etiologic factor. However, there are several links between the thyroid and parathyroid hormonal systems, and therefore other explanations are possible as well. In this study we investigate pre- and postoperative serum levels of thyroid hormones in 20 patients operated upon because of primary hyperparathyroidism. The mean (SD) serum levels of T4 increased from 16(2) pmol/l preoperatively to 21(6) pmol/l on the fourth postoperative day (P < 0.01), and four (20%) of the patients developed biochemical thyrotoxicosis in the immediate postoperative period. The serum levels of T4 on the fourth postoperative day correlated highly with preoperative serum levels of PTH (r = 0.75; P < 0.001). This suggests that biochemical thyrotoxicosis in the immediate postoperative period after operation for primary hyperparathyroidism is not uncommon and could be related to the disease rather than to surgical trauma.
|
|
| 9. |
- Bergenfelz, A, et al.
(författare)
-
Immunoheterogeneity of parathyroid hormone after surgery for primary hyperparathyroidism
- 1994
-
Ingår i: Clinica Chimica Acta. - 0009-8981. ; 231:2, s. 45-139
-
Tidskriftsartikel (refereegranskat)abstract
- Circulating parathyroid hormone (PTH) immunoheterogeneity is altered in primary hyperparathyroidism (pHPT). It is not known, however, whether the relative secretion of various PTH fragments differs between the adenomatous and the non-adenomatous glands in pHPT. We therefore examined the immunoheterogeneity of PTH in patients operated upon because of parathyroid adenoma pre- and 4 days postoperatively during an EDTA-infusion test. Following surgery, baseline levels of amino-terminal PTH (N-PTH) were reduced by a smaller degree than the levels of intact PTH (i-PTH) (P < 0.05) resulting in a higher N/i ratio postoperatively (P < 0.05). Furthermore, the increase in i-PTH and C-PTH fragments during the EDTA infusion test was lower postoperatively than preoperatively (P < 0.05), whereas the increase in N-PTH did not differ. The results therefore suggest that compared with the parathyroid adenoma, the non-adenomatous glands secrete relatively more N-terminal PTH.
|
|
| 10. |
- Bergenfelz, A, et al.
(författare)
-
Intact parathyroid hormone assay is superior to mid region assay in the EDTA-infusion test in hyperparathyroidism
- 1991
-
Ingår i: Clinica Chimica Acta. - 0009-8981. ; 197:3, s. 35-229
-
Tidskriftsartikel (refereegranskat)abstract
- We examined the use of an intact parathyroid hormone two-site immunoradiometric assay compared with a mid region parathyroid hormone radioimmunoassay in ethylene diamine tetraacetic acid-infusion test in 15 patients with hyperparathyroidism. During the test, plasma intact parathyroid hormone levels increased by 240 +/- 43%, whereas the plasma levels of mid molecule parathyroid hormone increased by only 65 +/- 17%, which is significantly lower (P less than 0.01). Four patients had no increase in plasma mid molecule parathyroid hormone level but still a large increase in plasma intact parathyroid hormone level (P less than 0.01). Thus, plasma measurement of intact parathyroid hormone is superior to that of mid molecule parathyroid hormone in the ethylene diamine tetraacetic acid-infusion test in patients with hyperparathyroidism.
|
|
